INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "DAROLUTAMIDE IN COMBINATION WITH BRAF AND MEK INHIBITORS FOR MELANOMA TREATMENT"

GENEVA, July 14 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/050017) for "DAROLUTAMIDE IN COMBINATION WITH BRAF AND MEK INHIBITORS FOR MELANOMA TREATMENT" on Jan 02, 2025. With publication no. WO/2025/146444, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAENDLER, Bernard (Am Biberbau 813465 Berlin), NEVEDOMSKAYA, Ekaterina (Schonhauser Allee 5510437 Berlin), REULE, Matthias (Damwildsteig 4613503 Berlin)

Abstract: The present invention relates to combinat...